Long-term virological outcome in children receiving first-line antiretroviral therapy
Abstract Background Studies relating to long-term virological outcomes among children on first-line antiretroviral therapy (ART) from low and middle-income countries are limited. Methods Perinatally HIV infected, ART-naive children, between 2 and 12 years of age, initiating NNRTI-based ART during 20...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | AIDS Research and Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12981-018-0208-9 |
id |
doaj-cc52ac63ae33436784aa9b456ca1b3d3 |
---|---|
record_format |
Article |
spelling |
doaj-cc52ac63ae33436784aa9b456ca1b3d32020-11-24T22:04:58ZengBMCAIDS Research and Therapy1742-64052018-11-0115111010.1186/s12981-018-0208-9Long-term virological outcome in children receiving first-line antiretroviral therapyPadmapriyadarsini Chandrasekaran0Anita Shet1Ramalingam Srinivasan2G. N. Sanjeeva3Sudha Subramanyan4Suba Sunderesan5Karunaianantham Ramesh6Bindu Gopalan7Elumalai Suresh8Navaneethan Poornagangadevi9Luke E. Hanna10Chockalingam Chandrasekar11Christine Wanke12Soumya Swaminathan13Department of Clinic Research, ICMR-National Institute for Research in TuberculosisJohns Hopkins Bloomberg School of Public HealthDepartment of Clinic Research, ICMR-National Institute for Research in TuberculosisIndira Gandhi Institute of Child HealthDepartment of Clinic Research, ICMR-National Institute for Research in TuberculosisSt Johns Research InstituteDepartment of Clinic Research, ICMR-National Institute for Research in TuberculosisSt Johns Research InstituteInstitute of Child Health and Government Hospital for ChildrenDepartment of Clinic Research, ICMR-National Institute for Research in TuberculosisDepartment of Clinic Research, ICMR-National Institute for Research in TuberculosisGovernment Hospital of Thoracic MedicineTufts University School of MedicineIndian Council of Medical ResearchAbstract Background Studies relating to long-term virological outcomes among children on first-line antiretroviral therapy (ART) from low and middle-income countries are limited. Methods Perinatally HIV infected, ART-naive children, between 2 and 12 years of age, initiating NNRTI-based ART during 2010–2015, with at least 12 months of follow-up, were included in the analysis. CD4 cell counts and plasma HIV-1 RNA were measured every 24 weeks post-ART initiation. Immunologic failure was defined as a decrease in the CD4 count to pre-therapy levels or below and virologic failure as HIV-RNA of > 1000 copies/ml at 48 weeks after ART initiation. Genotypic resistance testing was performed for children with virologic failure. Logistic regression analysis was done to identify predictors of virologic failure. Results Three hundred and ninety-three ART-naïve children living with HIV [mean (SD) age: 7.6 (3) years; mean (SD) CD4%: 16% (8); median (IQR) HIV-RNA: 5.1 (3.5–5.7) log10 copies/ml] were enrolled into the study. At 48 weeks, significant improvement occurred in weight-for-age and height-for-age z-scores from baseline (all p < 0.001). The immunologic response was good; almost 90% of children showing an increase in their absolute CD4+ T cell count to more than 350 cells/mm3. Immunological failure was noted among 11% (28/261) and virologic failure in 29% (94/328) of children. Of the 94 children with virologic failure at 12 months, 36 children showed immunologic failure while the rest had good immunologic improvement. There was no demonstrable correlation between virologic and immunologic failure. 62% had reported > 90% adherence to ART. At the time of virologic failure, multiple NNRTI-associated mutations were observed: 80%—K103N and Y181C being the major NNRTI mutations—observed. Sensitivity (95% CI) of immunologic failure to detect virologic failure was 7% (2–12), specificity 97% (92.4–98.9), PPV 44% (13.7–78.8) and NPV was 72% (65–77.9). There were no statistically significant predictors to detect children who will develop virologic failure on treatment. Conclusions Considerable immunological improvement is seen in children with ART initiation, but may not be an effective tool to monitor treatment response in the long-term. There is a lack of correlation between immunologic and virologic response while on ART, which may lead to a delay in identifying treatment failures. Periodic viral load monitoring is, therefore, a priority.http://link.springer.com/article/10.1186/s12981-018-0208-9Antiretroviral therapyPediatricsFirst-lineTreatment outcomeViral load |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Padmapriyadarsini Chandrasekaran Anita Shet Ramalingam Srinivasan G. N. Sanjeeva Sudha Subramanyan Suba Sunderesan Karunaianantham Ramesh Bindu Gopalan Elumalai Suresh Navaneethan Poornagangadevi Luke E. Hanna Chockalingam Chandrasekar Christine Wanke Soumya Swaminathan |
spellingShingle |
Padmapriyadarsini Chandrasekaran Anita Shet Ramalingam Srinivasan G. N. Sanjeeva Sudha Subramanyan Suba Sunderesan Karunaianantham Ramesh Bindu Gopalan Elumalai Suresh Navaneethan Poornagangadevi Luke E. Hanna Chockalingam Chandrasekar Christine Wanke Soumya Swaminathan Long-term virological outcome in children receiving first-line antiretroviral therapy AIDS Research and Therapy Antiretroviral therapy Pediatrics First-line Treatment outcome Viral load |
author_facet |
Padmapriyadarsini Chandrasekaran Anita Shet Ramalingam Srinivasan G. N. Sanjeeva Sudha Subramanyan Suba Sunderesan Karunaianantham Ramesh Bindu Gopalan Elumalai Suresh Navaneethan Poornagangadevi Luke E. Hanna Chockalingam Chandrasekar Christine Wanke Soumya Swaminathan |
author_sort |
Padmapriyadarsini Chandrasekaran |
title |
Long-term virological outcome in children receiving first-line antiretroviral therapy |
title_short |
Long-term virological outcome in children receiving first-line antiretroviral therapy |
title_full |
Long-term virological outcome in children receiving first-line antiretroviral therapy |
title_fullStr |
Long-term virological outcome in children receiving first-line antiretroviral therapy |
title_full_unstemmed |
Long-term virological outcome in children receiving first-line antiretroviral therapy |
title_sort |
long-term virological outcome in children receiving first-line antiretroviral therapy |
publisher |
BMC |
series |
AIDS Research and Therapy |
issn |
1742-6405 |
publishDate |
2018-11-01 |
description |
Abstract Background Studies relating to long-term virological outcomes among children on first-line antiretroviral therapy (ART) from low and middle-income countries are limited. Methods Perinatally HIV infected, ART-naive children, between 2 and 12 years of age, initiating NNRTI-based ART during 2010–2015, with at least 12 months of follow-up, were included in the analysis. CD4 cell counts and plasma HIV-1 RNA were measured every 24 weeks post-ART initiation. Immunologic failure was defined as a decrease in the CD4 count to pre-therapy levels or below and virologic failure as HIV-RNA of > 1000 copies/ml at 48 weeks after ART initiation. Genotypic resistance testing was performed for children with virologic failure. Logistic regression analysis was done to identify predictors of virologic failure. Results Three hundred and ninety-three ART-naïve children living with HIV [mean (SD) age: 7.6 (3) years; mean (SD) CD4%: 16% (8); median (IQR) HIV-RNA: 5.1 (3.5–5.7) log10 copies/ml] were enrolled into the study. At 48 weeks, significant improvement occurred in weight-for-age and height-for-age z-scores from baseline (all p < 0.001). The immunologic response was good; almost 90% of children showing an increase in their absolute CD4+ T cell count to more than 350 cells/mm3. Immunological failure was noted among 11% (28/261) and virologic failure in 29% (94/328) of children. Of the 94 children with virologic failure at 12 months, 36 children showed immunologic failure while the rest had good immunologic improvement. There was no demonstrable correlation between virologic and immunologic failure. 62% had reported > 90% adherence to ART. At the time of virologic failure, multiple NNRTI-associated mutations were observed: 80%—K103N and Y181C being the major NNRTI mutations—observed. Sensitivity (95% CI) of immunologic failure to detect virologic failure was 7% (2–12), specificity 97% (92.4–98.9), PPV 44% (13.7–78.8) and NPV was 72% (65–77.9). There were no statistically significant predictors to detect children who will develop virologic failure on treatment. Conclusions Considerable immunological improvement is seen in children with ART initiation, but may not be an effective tool to monitor treatment response in the long-term. There is a lack of correlation between immunologic and virologic response while on ART, which may lead to a delay in identifying treatment failures. Periodic viral load monitoring is, therefore, a priority. |
topic |
Antiretroviral therapy Pediatrics First-line Treatment outcome Viral load |
url |
http://link.springer.com/article/10.1186/s12981-018-0208-9 |
work_keys_str_mv |
AT padmapriyadarsinichandrasekaran longtermvirologicaloutcomeinchildrenreceivingfirstlineantiretroviraltherapy AT anitashet longtermvirologicaloutcomeinchildrenreceivingfirstlineantiretroviraltherapy AT ramalingamsrinivasan longtermvirologicaloutcomeinchildrenreceivingfirstlineantiretroviraltherapy AT gnsanjeeva longtermvirologicaloutcomeinchildrenreceivingfirstlineantiretroviraltherapy AT sudhasubramanyan longtermvirologicaloutcomeinchildrenreceivingfirstlineantiretroviraltherapy AT subasunderesan longtermvirologicaloutcomeinchildrenreceivingfirstlineantiretroviraltherapy AT karunaiananthamramesh longtermvirologicaloutcomeinchildrenreceivingfirstlineantiretroviraltherapy AT bindugopalan longtermvirologicaloutcomeinchildrenreceivingfirstlineantiretroviraltherapy AT elumalaisuresh longtermvirologicaloutcomeinchildrenreceivingfirstlineantiretroviraltherapy AT navaneethanpoornagangadevi longtermvirologicaloutcomeinchildrenreceivingfirstlineantiretroviraltherapy AT lukeehanna longtermvirologicaloutcomeinchildrenreceivingfirstlineantiretroviraltherapy AT chockalingamchandrasekar longtermvirologicaloutcomeinchildrenreceivingfirstlineantiretroviraltherapy AT christinewanke longtermvirologicaloutcomeinchildrenreceivingfirstlineantiretroviraltherapy AT soumyaswaminathan longtermvirologicaloutcomeinchildrenreceivingfirstlineantiretroviraltherapy |
_version_ |
1725827981276872704 |